Melasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy
Wolfgang Philipp-Dormston
DOI: https://doi.org/10.2147/ccid.s372456
2024-05-23
Clinical Cosmetic and Investigational Dermatology
Abstract:Wolfgang G Philipp-Dormston 1, 2 1 Hautzentrum Köln/Cologne Dermatology, Cologne, Germany; 2 Faculty of Health, University of Witten/Herdecke, Witten, Germany Correspondence: Wolfgang G Philipp-Dormston, Hautzentrum Köln/Cologne Dermatology, Schillingsrotter Str. 39-41, Cologne, 50996, Germany, Tel +49 221 39800 200, Fax +49-221-39800 201, Email Melasma is a common challenge in the field of pigmentary skin disorders, exerting a significant emotional and psychosocial burden on patients. The persistent and recurring nature of melasma complicates its management in routine clinical practice. This comprehensive review outlines a stepwise, practical approach encompassing diagnostic, preventive and therapeutic strategies for the management of melasma. A thorough exploration of aggravating and exacerbating factors, including sun exposure, hormonal imbalances, photosensitizing medication and cosmetics, is essential for a holistic assessment of the disease. With an emphasis on consistent and effective photoprotection, initial topical treatment modalities target the melanin production and/or the transfer of melanosomes to keratinocytes. Topical tyrosine inhibitors emerge as the first choice for reducing and preventing hyperpigmentation, with compounds such as thiamidol or tranexamic acid (TXA) being preferred for their safety profile over hydroquinone (HQ), kojic acid and arbutin. Combination with chemical peels can further enhance the therapeutic efficacy, even in cases with resistant melasma. In more severe cases, laser- and light-based interventions may be considered, but with the caveat of the likelihood of recurrence within 3– 6 months. Assisted TXA delivery, via either fractional non-ablative laser or microneedling techniques, can further improve clinical outcomes. In conclusion, an optimal melasma management strategy is a multimodal approach, which includes effective photoprotection and a mix of different topical treatments targeting melanin synthesis, the anti-inflammatory environment, senescence and vascularity. Complementary procedures, such as chemical peels, and laser, light-based or microneedling procedures, with or without TXA, can further expedite melanin clearance in more severely affected instances. Individual discussions with patients regarding treatment expectations, recurrence likelihood and potential side effects are paramount to a comprehensive and successful therapeutic journey. Keywords: melasma, chloasma, hyperpigmentation, melanosis Melasma (syn. chloasma) presents as distinct, symmetrically patterned, hyperpigmented patches or small spots that occur predominantly on sun-exposed areas of the face. While its predominant location is generally centrofacial, affecting 50–80% of cases, melasma can also manifest on malar and mandibular areas. 1,2 The prevalence of melasma exhibits striking variability across populations and ethnicities, with reported overall prevalence rates ranging from of 1% in the general population to as high as 9–50% in high-risk populations, particularly dark-skinned women (Fitzpatrick phototypes III–IV) in their third and fourth decades of life. 3 Despite being a common and predominantly benign condition, melasma carries a considerable emotional and psychosocial burden, profoundly affecting the patient's self-esteem and overall quality of life. 4,5 Given its persistence and recurring nature, effectively managing patient expectations and implementing preventive and therapeutic interventions tailored to the severity and underlying pathophysiology are paramount. However, reviews providing a practical treatment pathway for the management of melasma are limited. This comprehensive review outlines a stepwise, up-to-date practical approach encompassing diagnostic, preventive and therapeutic strategies for the management of melasma to facilitate its management in everyday clinical practice. The pathogenesis of melasma is multifactorial and not yet fully understood; various internal and environmental factors can contribute to triggering, maintaining and the relapsing of lesions 6,7 (Table 1). Among these, the most important factors are genetic predisposition, sun exposure and hormonal imbalances, especially as they occur in the context of pregnancy ("mask of pregnancy") or when taking contraceptives. All of them can significantly increase tyrosinase activity. In addition, chronic inflammatory skin diseases, photosensitizing interventions, drugs or food, liver diseases, ovarian tumors, helminthiasis, and even increased stress can cause melasma. 8 Table 1 Factors Contributing to Melasma Pathogenesis and Diagnostic Work-Up As a concomitant disease, melasma is more often diagnosed in patients with polycystic ovary syndrome, insulin resistance or thyroid dysfunction. Further -Abstract Truncated-
dermatology